Skip to content
Surgical Oncology

Carcinoid Tumor Surgery

About This Department

 
Surgical Oncology

Remove the tumor, its lymph nodes and the liver disease that can safely go. With octreotide ready against carcinoid crisis.

In a Mayo Clinic series, half of patients with small bowel carcinoid had more than one tumor in the bowel and 92 percent had lymph node spread, which is why the operation includes the nodes and a check of the whole bowel.

51%
Small bowel NETs with more than one tumor
61%
Five-year survival after liver resection, Mayo series
10 days
Published Turkey package, days in country
Free
Case review
Free consultation
Send your DOTATATE PET-CT, CT or MRI and pathology report on WhatsApp, and our surgical oncology team will review the options for your tumor.

Carcinoid tumors grow from hormone-making cells scattered through the gut and lungs, and doctors now call them well-differentiated neuroendocrine tumors, or NETs. Many grow slowly for years. Some turn up by chance during an appendix operation or a colonoscopy, while others announce themselves through flushing and diarrhea once they have reached the liver. Only surgery can remove the disease completely, and even when cure is out of reach, taking out the primary tumor, the lymph nodes around it and as much liver disease as is safe can ease symptoms and lengthen life. This guide covers where carcinoid tumors arise, the tests that come first, how small bowel, appendix, rectal, stomach and lung tumors are operated on, liver surgery, protection against carcinoid crisis during the operation, treatment afterwards, the recovery, how long to stay in Istanbul and the follow-up at home.

What a carcinoid tumor is

The main sites, in rough order of frequency, are

  • the small bowel, mostly its last part, the ileum,
  • the lungs and airways,
  • the rectum and the appendix,
  • and the stomach.
1
Finding it
A scan, an endoscopy or an operation for something else reveals the tumor.
2
Grading it
The pathologist measures how fast the cells divide.
3
Staging it
Scans show whether lymph nodes or the liver hold disease, and together with the grade this sets the plan.

Neuroendocrine cells release hormones such as serotonin into the blood. When they form a tumor, the pathologist grades it by how fast its cells divide, measured with a stain called Ki-67. Grade guides treatment.

On a narrow screen, swipe the table sideways to read every column.

How neuroendocrine tumors are graded
Grade Ki-67 index Usual behavior
Grade 1 Below 3 percent Slow growth over years
Grade 2 3 to 20 percent Moderate growth
Grade 3 Above 20 percent Faster growth, often treated with drugs first

An analysis of the American SEER cancer registry found that the yearly rate of new neuroendocrine tumors rose 6.4-fold between 1973 and 2012, to 6.98 per 100,000 people, with the increase seen at every site and stage. Better scans and more endoscopy explain part of that rise, because tumors that once went unnoticed until they caused symptoms are now found early on images taken for other reasons, and many of these small tumors can be removed completely with a short operation. Survival improved over the same years, most of all for tumors that had already spread.

Carcinoid syndrome and the heart

Carcinoid syndrome
Flushing of the face and neck, watery diarrhea and wheezing appear when serotonin and related substances reach the general circulation, which in gut tumors mostly happens once the liver holds deposits.
Carcinoid heart disease
Years of high serotonin can thicken and stiffen the valves on the right side of the heart. An echocardiogram before surgery checks for it, and badly damaged valves are sometimes replaced before abdominal surgery.
Removing the hormone-making tissue is the most direct way to quiet the syndrome.

Tests before the operation

Scans come first. Each test answers a different question.

1
DOTATATE PET-CT
Lights up tumor cells that carry somatostatin receptors and maps spread to lymph nodes, liver and bone.
2
CT or liver MRI
Adds anatomical detail for planning the operation.
3
Blood and urine markers
Chromogranin A in the blood and a 24-hour urine test for 5-HIAA, a breakdown product of serotonin, give a baseline to follow after surgery.
4
Echocardiogram
Checks the heart valves in anyone with carcinoid syndrome.
Why the scan does not replace the surgeon's hands
In a Mayo Clinic series of 104 small bowel NETs, 51 percent of patients had more than one tumor in the bowel at surgery, and the PET-CT reports had picked up multiple tumors in only 45 percent of those cases. The authors concluded that the scan cannot replace feeling the whole small bowel during the operation.

For the review, please send

  1. the PET-CT and CT or MRI images on disc or by download link,
  2. the pathology report with the Ki-67 grade,
  3. any chromogranin A or 5-HIAA results,
  4. and a list of the medicines you take, including any octreotide or lanreotide injections.

Small bowel carcinoid surgery

The operation

1
Exploring the abdomen
The surgeon examines the liver, the lining of the abdomen and the ovaries in women for deposits.
2
Feeling the bowel
The whole small bowel passes through the surgeon's fingers.
3
Removing the segment and nodes
The tumor-bearing segment comes out with a wedge of mesentery and its lymph nodes, sparing the main blood vessels.
4
Joining the bowel
The two ends are stitched together, and the gallbladder is often removed in the same operation if long-term somatostatin drugs are planned, because these drugs cause gallstones.

Lymph node spread is the rule in small bowel carcinoid. In the same Mayo series, 92 percent of patients had cancer in the nodes. A hard, scarred mass around the mesenteric vessels, caused by the tumor's fibrous reaction, can choke the bowel's blood supply and cause pain after meals or blockage, so clearing these nodes protects the remaining bowel even when the liver already holds disease. Open surgery suits this work. Keyhole surgery with a small hand-assist cut serves selected patients.

Appendix, rectum, stomach and lung

The site table also scrolls sideways on small screens.

Usual surgery by tumor site
Site Smaller tumors Larger or invasive tumors
Appendix Appendectomy alone below 1 cm Right hemicolectomy above 2 cm or with risk features
Rectum Endoscopic removal below 1 cm Rectal resection with lymph nodes
Stomach Endoscopic removal or surveillance for type 1 Partial gastrectomy for type 3
Lung Segmentectomy or lobectomy Lobectomy with lymph node dissection
Tumor size and depth decide how much tissue comes out.
Appendix tumors of 1 to 2 cm
Spread into the fat around the appendix, a tumor at its base or lymphatic invasion tips the decision toward a right hemicolectomy.
Pancreatic NETs
Pancreatic neuroendocrine tumors follow their own rules, set by size and hormone production, and are covered on our pancreatectomy page.

When the tumor has reached the liver

A Mayo Clinic study followed 170 patients who had liver resection for neuroendocrine metastases, 120 of them carcinoid. Two patients died after surgery, and complications occurred in 14 percent. The operation controlled symptoms in 104 of 108 patients with hormone symptoms. Five-year survival reached 61 percent and ten-year survival 35 percent, although the disease came back in the liver or elsewhere in 84 percent by five years. Surgeons therefore aim to remove at least most of the visible liver disease, combining resection with ablation of small deposits, and reserve the approach for grade 1 and 2 tumors where the primary can also be removed. Surgery bought time. The same study found that no patient developed carcinoid heart disease after the operation, and urine 5-HIAA levels fell sharply, which matters because those levels drive the valve damage described above. When deposits fill both lobes, the operation can be split into two stages a few weeks apart so that the remaining liver has time to grow.

  • Liver resection removes one or more segments or a whole lobe.
  • Ablation destroys small deposits with heat from a needle probe placed under ultrasound guidance during the same operation.
  • Embolization blocks the blood supply of deposits that cannot be removed.

Protecting against carcinoid crisis

Handling a hormone-active tumor can release a flood of serotonin. Blood pressure then drops. An American center gave a continuous high-dose octreotide drip before, during and after 179 operations for advanced small bowel NETs and recorded crisis in 3.4 percent. A Mayo Clinic review of 169 liver resections found no confirmed crisis at all.

On the day
The anesthetist keeps octreotide ready for every carcinoid operation, and patients with syndrome or heart disease are monitored with an arterial line.

Treatment after surgery

Somatostatin analog injections
Monthly octreotide or lanreotide injections control hormone symptoms and slow growth of disease that remains.
PRRT
Radioactive treatment aimed at the tumor's receptors.
Chemotherapy and targeted drugs
These drugs serve mainly grade 3 or fast-growing tumors. Chemotherapy, radiotherapy and immunotherapy all run on the same hospital site, so treatment after surgery continues without a transfer between teams or buildings.

The recovery

In hospital

Walking starts the day after surgery. Sips of fluid come first. Most bowel operations mean five to seven days on the ward, and major liver surgery a little longer.

The first weeks

Loose stools follow a long ileal resection or right hemicolectomy and settle over weeks, helped by diet changes and medicine. Avoid lifting more than a few kilograms for six weeks after open surgery. Fatigue fades slowly.

How long to stay in Istanbul

Plan for two to three weeks.

Small intestine resection packages listed on Bookimed for Turkish hospitals give ten days in the country, and published Istanbul packages range from five to eleven nights on the ward. We plan longer so that the final pathology report, the first wound check and the treatment plan for any remaining disease are ready before you fly. Liver surgery adds about a week.

What decides the cost

The site of the tumor, open or keyhole surgery, whether liver disease is treated in the same operation, the nights in hospital and the drugs that follow shape the estimate. Your scans and pathology report let our team prepare it at no charge.

Arranging the trip

The documents listed under the tests above, sent on WhatsApp, open the review. Your coordinator then plans tests, admission and hotel nights around the operation. A relative stays on the companion bed, and seven languages are spoken by the staff, with interpreters for others. The international office books the hotel, sends the visa invitation letter ten days before travel and arranges airport transfers, and halal, vegetarian and diabetic meals, a prayer room and a female physician are available on request.

Once you are back home

Follow-up lasts years. Carcinoid tumors can recur a decade after surgery. Scans and blood or urine markers are repeated every three to six months at first, then yearly, for at least ten years. Your coordinator stays reachable for questions and new results. Seek care quickly for cramping pain with vomiting, a swollen belly, or new flushing and diarrhea.

Carcinoid tumor surgery FAQ

Is a carcinoid tumor cancer?
Yes. Most grow slowly, but they can spread to lymph nodes and the liver.
Can surgery cure it?
Often, when the tumor is caught before it spreads beyond the nodes.
Is surgery worthwhile if the liver is affected?
In selected patients it relieves symptoms and lengthens life.
Will I need injections afterwards?
Only if disease remains or the risk of return is high.
Can a family member stay with me?
Yes, on the companion bed in your room throughout the hospital stay.

References

  1. Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335-1342. doi:10.1001/jamaoncol.2017.0589
  2. Zhang C, Gudmundsdottir H, Takahashi H, et al. Accuracy of DOTATATE PET imaging in the preoperative planning of small bowel neuroendocrine tumor resection. J Surg Oncol. 2023;128(7):1072-1079. doi:10.1002/jso.27413
  3. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197(1):29-37. doi:10.1016/S1072-7515(03)00230-8
  4. Woltering EA, Wright AE, Stevens MA, et al. Development of effective prophylaxis against intraoperative carcinoid crisis. J Clin Anesth. 2016;32:189-193. doi:10.1016/j.jclinane.2016.03.008
  5. Kinney MAO, Nagorney DM, Clark DF, et al. Partial hepatic resections for metastatic neuroendocrine tumors: perioperative outcomes. J Clin Anesth. 2018;51:93-96. doi:10.1016/j.jclinane.2018.08.005

Editor's note

Written by the Biruni Hospital medical editorial team. Reviewed by Prof. Dr. Mustafa Teoman YANMAZ, Medical Oncology.

Last updated:

Related Treatments

View All